Market Currents
Achillion Pharmaceuticals (ACHN +11.5%) jumps after pricing its secondary offering at $5.90, a...
-
Wednesday, June 22, 2011, 9:52 AM ETAchillion Pharmaceuticals (ACHN +11.5%) jumps after pricing its secondary offering at $5.90, a 1.8% discount to yesterday's close. The company plans to use the $52M it raised to bring its new line of hepatitis-c drugs to market.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
